当前位置:首页 - 行情中心 - 华邦健康(002004) - 财务分析 - 现金流量表

华邦健康

(002004)

  

流通市值:81.31亿  总市值:85.53亿
流通股本:18.82亿   总股本:19.80亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金8,012,354,304.995,196,161,747.762,533,343,950.1211,978,160,515.03
收到的税费返还332,828,580.65259,239,100.34102,103,977.09733,024,462.5
收到其他与经营活动有关的现金227,802,363.16113,672,373.4692,163,807.57262,297,240.28
经营活动现金流入的平衡项目0000
经营活动现金流入小计8,572,985,248.85,569,073,221.562,727,611,734.7812,973,482,217.81
购买商品、接受劳务支付的现金3,988,570,458.472,915,700,781.61,545,064,302.535,940,221,568.47
支付给职工以及为职工支付的现金1,544,231,181.871,035,070,588.44559,146,643.31,743,682,364.93
支付的各项税费831,261,708.3559,535,150.22242,084,144.241,010,980,717.01
支付其他与经营活动有关的现金1,238,332,264.84809,717,893.5394,130,314.631,870,742,223.44
经营活动现金流出的平衡项目0000
经营活动现金流出小计7,602,395,613.485,320,024,413.762,740,425,404.710,565,626,873.85
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额970,589,635.32249,048,807.8-12,813,669.922,407,855,343.96
二、投资活动产生的现金流量:
收回投资收到的现金4,758,899,106.193,937,379,816.972,577,317,650.037,726,816,992.37
取得投资收益收到的现金90,723,115.376,881,565.2622,949,303.5181,946,616.91
处置固定资产、无形资产和其他长期资产收回的现金净额63,317,691.9350,107,194.13408,655.8935,922,081.7
收到的其他与投资活动有关的现金300,846,399.67215,602,528.6519,050,000282,169,000.25
投资活动现金流入的平衡项目0000
投资活动现金流入小计5,213,786,313.094,279,971,105.012,619,725,609.428,226,854,691.23
购建固定资产、无形资产和其他长期资产支付的现金918,426,602.07622,979,984.05300,060,445.551,131,174,729.15
投资支付的现金4,373,607,079.763,231,863,479.762,229,345,540.967,141,847,069
取得子公司及其他营业单位支付的现金3,946,097.183,946,097.18015,841,261.75
支付其他与投资活动有关的现金327,404,853205,174,299137,814,000494,484,282.2
投资活动现金流出的平衡项目0000
投资活动现金流出小计5,623,384,632.014,063,963,859.992,667,219,986.518,783,347,342.1
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-409,598,318.92216,007,245.02-47,494,377.09-556,492,650.87
三、筹资活动产生的现金流量:
吸收投资收到的现金3,000,0003,000,0002,000,00034,126,600
其中:子公司吸收少数股东投资收到的现金3,000,0003,000,0002,000,00034,126,600
取得借款收到的现金6,658,972,517.213,982,560,150.671,414,745,9007,037,709,994.59
收到其他与筹资活动有关的现金612,134,036.97385,210,117.07271,341,170.39903,100,875.18
筹资活动现金流入平衡项目0000
筹资活动现金流入小计7,274,106,554.184,370,770,267.741,688,087,070.397,974,937,469.77
偿还债务支付的现金6,365,781,000.583,566,275,206.491,382,130,206.927,897,817,901.98
分配股利、利润或偿付利息支付的现金908,083,468.2661,650,712.1102,921,503.741,011,232,976.75
其中:子公司支付给少数股东的股利、利润226,520,144.01130,690,160.422,001,810156,822,551.47
支付其他与筹资活动有关的现金464,973,685.44321,884,686.11210,131,520.35436,147,862.98
筹资活动现金流出平衡项目0000
筹资活动现金流出小计7,738,838,154.224,549,810,604.71,695,183,231.019,345,198,741.71
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-464,731,600.04-179,040,336.96-7,096,160.62-1,370,261,271.94
四、汇率变动对现金及现金等价物的影响1,037,342.11497,209.15-11,413,514.647,263,406.18
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额97,297,058.47286,512,925.01-78,817,722.27488,364,827.33
加:期初现金及现金等价物余额2,991,321,110.932,991,321,110.932,991,321,110.932,502,956,283.6
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,088,618,169.43,277,834,035.942,912,503,388.662,991,321,110.93
补充资料:
净利润-646,408,796.67-1,126,736,284.38
资产减值准备--7,177,891.43-583,634,921.11
固定资产和投资性房地产折旧-368,212,720.81-678,235,614.41
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-368,212,720.81-678,235,614.41
无形资产摊销-52,029,480.29-92,914,348
长期待摊费用摊销-40,280,694.81-87,873,988.14
处置固定资产、无形资产和其他长期资产的损失-442,729-8,775,438.8
固定资产报废损失-852,271.5-12,488,514.33
公允价值变动损失-3,344,037.12-4,836,838.69
财务费用-142,593,658.01-365,442,239.05
投资损失--36,937,001.26--441,485,183.53
递延所得税--32,626,747.08--68,609,981.33
其中:递延所得税资产减少--28,506,646.6--70,492,494.26
递延所得税负债增加--4,120,100.48-1,882,512.93
存货的减少--309,102,518.94--154,582,838.58
经营性应收项目的减少--336,524,032.67-59,612,816.25
经营性应付项目的增加--321,203,743.02-1,458,707.51
其他-22,406,931.03-21,444,535.76
现金的期末余额-3,277,834,035.94-2,991,321,110.93
减:现金的期初余额-2,991,321,110.93-2,502,956,283.6
公告日期2023-10-312023-08-292023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑